Birdwatch Note
2023-12-04 18:01:05 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Remdesivir was *approved* for use against COVID in some countries, it was never one that was compulsory, and was never the only drug physicians were permitted to use. It is not associated with an increased risk of kidney failure. https://en.wikipedia.org/wiki/Remdesivir https://en.m.wikipedia.org/wiki/Treatment_and_management_of_COVID-19
Written by 5A27AD0D25D23BA99B801A6D54134E502C93AFC29FB9BD946F7C814F0602AA6C
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1730272634179559705
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1731735388090474752
- noteId - 1731735388090474752
- participantId -
- noteAuthorParticipantId - 5A27AD0D25D23BA99B801A6D54134E502C93AFC29FB9BD946F7C814F0602AA6C Participant Details
- createdAtMillis - 1701712865265
- tweetId - 1730272634179559705
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Remdesivir was *approved* for use against COVID in some countries, it was never one that was compulsory, and was never the only drug physicians were permitted to use. It is not associated with an increased risk of kidney failure. https://en.wikipedia.org/wiki/Remdesivir https://en.m.wikipedia.org/wiki/Treatment_and_management_of_COVID-19
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-12-04 18:01:05 UTC (1701712865265) |
1969-12-31 23:59:59 UTC (-1) |
2023-12-05 03:33:02 UTC (1701747182239) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-12-04 17:36:48 -0600 | Rating Details | |
2023-12-04 14:39:46 -0600 | Rating Details | |
2023-12-04 13:31:43 -0600 | Rating Details | |
2023-12-04 13:01:21 -0600 | Rating Details | |
2023-12-05 17:47:29 -0600 | Rating Details | |
2023-12-05 14:49:08 -0600 | Rating Details | |
2023-12-05 14:31:14 -0600 | Rating Details | |
2023-12-05 13:27:35 -0600 | Rating Details | |
2023-12-04 21:55:52 -0600 | Rating Details | |
2023-12-04 21:36:18 -0600 | Rating Details | |
2023-12-04 18:57:54 -0600 | Rating Details | |
2023-12-05 22:13:06 -0600 | Rating Details | |
2023-12-05 21:23:53 -0600 | Rating Details | |
2023-12-05 19:55:45 -0600 | Rating Details | |
2023-12-05 19:49:00 -0600 | Rating Details | |
2023-12-05 19:44:34 -0600 | Rating Details | |
2023-12-04 18:56:30 -0600 | Rating Details | |
2023-12-04 18:42:30 -0600 | Rating Details | |
2023-12-04 12:30:57 -0600 | Rating Details | |
2023-12-04 12:20:17 -0600 | Rating Details | |
2023-12-06 19:34:25 -0600 | Rating Details | |
2023-12-08 09:19:49 -0600 | Rating Details | |
2023-12-07 21:13:26 -0600 | Rating Details | |
2023-12-09 17:43:07 -0600 | Rating Details | |
2023-12-08 21:31:08 -0600 | Rating Details | |
2023-12-10 14:07:27 -0600 | Rating Details | |
2023-12-10 00:45:53 -0600 | Rating Details | |
2023-12-10 00:37:39 -0600 | Rating Details | |
2023-12-10 00:29:34 -0600 | Rating Details | |
2023-12-09 19:01:06 -0600 | Rating Details | |
2023-12-11 13:13:53 -0600 | Rating Details | |
2023-12-11 12:54:01 -0600 | Rating Details | |
2023-12-11 04:18:33 -0600 | Rating Details | |
2023-12-10 18:41:58 -0600 | Rating Details | |
2023-12-11 23:04:54 -0600 | Rating Details | |
2023-12-11 19:14:57 -0600 | Rating Details | |
2023-12-13 01:13:38 -0600 | Rating Details | |
2023-12-12 20:26:33 -0600 | Rating Details | |
2023-12-15 20:31:27 -0600 | Rating Details | |
2024-07-12 08:56:57 -0500 | Rating Details | |
2024-07-09 17:36:13 -0500 | Rating Details | |
2024-07-09 14:37:09 -0500 | Rating Details | |
2024-07-07 15:18:06 -0500 | Rating Details | |
2024-07-06 13:41:01 -0500 | Rating Details | |
2024-07-06 12:41:58 -0500 | Rating Details | |
2024-07-04 07:58:07 -0500 | Rating Details | |
2024-07-04 03:21:28 -0500 | Rating Details | |
2024-07-03 09:41:15 -0500 | Rating Details |